AXIM — Axim Biotechnologies Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $1.19m
- $7.79m
- $0.04m
Brief: Axim Biotechnologies Inc Develops Next Generation Of Its Rapid Neutralizing Antibody Test For Covid-19
Brief: AXIM Biotechnologies To Acquire Technology Including
Brief: Axim® Biotechnologies Successfully Completes Point-Of-Care Clinical Trials On Its Rapid Covid-19 Neutralizing Antibody Test
Brief: Axim Biotechnologies Inc Says Filed A Provisional Patent For A First-In-Class Face Mask That Captures And Deactivates Sars-Cov-2
Brief: Axim Biotechnologies Signs Exclusive Licensing, Manufacturing And Distribution Agreement For Production Of COVID-19 Rapid Neutralizing Antibody Test
Brief: Axim Biotechnologies Unveils Covid-19 Rapid Diagnostic Test For Neutralizing Antibodies
Brief: Axim Gets New U.S. Patent Issuance For Cannabinoids And Nicotine Chewing Gum To Treat Tobacco Smoking
Brief: AXIM Biotechnologies Nutraceutical Division Announces Launch Of CBD-Based Gum For Professional And Amateur Golfers
Brief: Axim Biotechnologies Acquiree Sapphire Biotech Signs License Agreement To Exclusively License Patent Rights In Cancer Technology
Brief: Medical Marijuana, Inc. Investment Company Axim Biotechnologies To Acquire Sapphire Biotech
Brief: Axim Biotechnologies Signed Cultivation Agreement With Hemp Farm In North Carolina
Brief: New U.S. Patent Allowance Granted To Axim Biotechnologies For Anti-Microbial Compositions Comprising Cannabinoids
Brief: Medical Marijuana, Inc. Major Investment Company Axim® Biotechnologies Files New U.S. Provisional Patent For Cannabis Gum As A Treatment For Migraine Symptoms
Brief: Axim Biotechnologies Receives New U.S. Patent Issuance For Topical Cream Containing Cannabinoids
Analysis: Patents on pot? US lawsuit puts cannabis claims to the test
Brief: New U.S. Patent Allowance Granted To Axim Biotechnologies
Brief: Axim Biotechnologies announces phase IIa trial results validating its proprietary cannabinoid delivery method
Brief: Axim Biotech, University Of British Columbia ink clinical study deal
High hopes ride on marijuana painkillers amid opioid crisis